Skip to main content

Alpine Peaks Capital, LP

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1906602 NEW YORK, NY

Position in MRVI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
13 quarters on record

Common Shares in MRVI Over Time

Shares Held

Position Value (USD)

Derivatives in MRVI

reported options exposure · as of Mar 31, 2026
CallValue
$283,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Alpine Peaks Capital, LP holds $3,867,240 across 1 Biotechnology name.

# Ticker Company Shares Value (USD) Open

All Filings in MRVI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $283,000 100,000
2025-12-31 $314,925 96,900
2025-09-30 $414,715 144,500
2025-03-31 $534,820 242,000
2024-12-31 $1,111,800 204,000
2024-09-30 $2,318,689 279,024
2024-06-30 $2,125,804 296,900
2024-03-31 $3,233,043 372,900
2023-12-31 $2,652,095 404,900
2023-09-30 $3,593,000 359,300
2023-06-30 $4,094,740 329,424
2023-03-31 $3,369,405 240,500
2022-12-31 $2,597,265 181,500